Low grade supratentorial astrocytomas. Management and prognostic factors
…, F Kwiatkowski, JJ Lemaire, R Plagne, R Rozan - Cancer, 1994 - Wiley Online Library
Background. The authors examined the principal prognostic factors for supratentorial low
grade astrocytomas and the effects of treatment on survival time. Methods. Fifty‐eight patients, …
grade astrocytomas and the effects of treatment on survival time. Methods. Fifty‐eight patients, …
Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma
…, C Dionet, F Kwiatkowski, R Plagne… - JNCI: Journal of the …, 1991 - academic.oup.com
In 20 women with breast carcinoma, 17 of whom had locally advanced cancer and 3 of whom
had confirmed metastases, the expression of P-glycoprotein was evaluated before the start …
had confirmed metastases, the expression of P-glycoprotein was evaluated before the start …
[PDF][PDF] Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide)
…, PG Labarre, P Kauffmann, RJ Plagne - Journal of Nuclear …, 1993 - Soc Nuclear Med
RESULTS After injection of â€@ I-BZA, no short-term or long term side effects were observed.
The investigators ob served normal quickly distributed radioactivity in blood circulation. …
The investigators ob served normal quickly distributed radioactivity in blood circulation. …
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and …
JL Misset, M di Palma, M Delgado, R Plagne… - Journal of clinical …, 1996 - ascopubs.org
PURPOSE To determine the long-term impact on disease-free survival (DFS) and overall
survival (OS) of adjuvant anthracycline-based chemotherapy, when prospectively compared by …
survival (OS) of adjuvant anthracycline-based chemotherapy, when prospectively compared by …
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.
…, F Tavernier, C Glenat, P Chollet, R Plagne - Journal of clinical …, 1997 - ascopubs.org
PURPOSE A series of 53 patients with poor-prognosis epithelial ovarian cancer treated with
high-dose chemotherapy (HDC) followed by hematopoietic rescue was retrospectively …
high-dose chemotherapy (HDC) followed by hematopoietic rescue was retrospectively …
Dihydropyrimidine dehydrogenase activity in cancer patients
…, F Demard, RA Fleming, PJ Bargnoux, R Plagne - European Journal of …, 1993 - Elsevier
Dihydropyrimidine dehydrogenase (DPD) is the major catabolic enzyme of pyrimidines and
fluoropyrimidines. The clinical course of 2 patients with suspected DPD deficiency is …
fluoropyrimidines. The clinical course of 2 patients with suspected DPD deficiency is …
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer
…, O Tournilhac, P Travade, R Plagne… - Bone marrow …, 2000 - nature.com
A 33-year-old woman developed progressive ovarian cancer resistant to classical chemotherapy
agents. We performed a bone marrow allograft after a myeloablative regimen. During …
agents. We performed a bone marrow allograft after a myeloablative regimen. During …
Genotypic analyses of Richter's syndrome
…, F Ramos, Y Fonck, F Courjal, P Chollet, R Plagne… - Cancer, 1991 - Wiley Online Library
Authors report the immunogenotype of two cases of Richter's syndrome. The immunoglobulin
gene rearrangement pattern obtained on Southern Blot analysis was found in both cases …
gene rearrangement pattern obtained on Southern Blot analysis was found in both cases …
Second‐look laparotomy in managing epithelial ovarian carcinoma
…, M Gorbinet, M Legros, P Chollet, B Giraud, R Plagne - Cancer, 1986 - Wiley Online Library
Fifty‐one patients treated for an epithelial ovarian carcinoma underwent a second‐look
operation (SLO) from August 1979 to December 1984. Previously, an initial laparotomy had been …
operation (SLO) from August 1979 to December 1984. Previously, an initial laparotomy had been …
High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation
…, P Condat, JP Ferriere, SB Ahmed, R Plagne - Gynecologic …, 1989 - Elsevier
Patients with epithelial ovarian carcinoma (OVCA) and positive second-look operation (SLO)
have a poor short-term prognosis. Treatment after SLO is still controversial and pilot studies …
have a poor short-term prognosis. Treatment after SLO is still controversial and pilot studies …